» Articles » PMID: 34165714

An Overview of the Computational Models Dealing with the Regulatory CeRNA Mechanism and CeRNA Deregulation in Cancer

Overview
Specialty Molecular Biology
Date 2021 Jun 24
PMID 34165714
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Pools of RNA molecules can act as competing endogenous RNAs (ceRNAs) and indirectly alter their expression levels by competitively binding shared microRNAs. This ceRNA cross talk yields an additional posttranscriptional regulatory layer, which plays key roles in both physiological and pathological processes. MicroRNAs can act as decoys by binding multiple RNAs, as well as RNAs can act as ceRNAs by competing for binding multiple microRNAs, leading to many cross talk interactions that could favor significant large-scale effects in spite of the weakness of single interactions. Identifying and studying these extended ceRNA interaction networks could provide a global view of the fine-tuning gene regulation in a wide range of biological processes and tumor progressions. In this chapter, we review current progress of predicting ceRNA cross talk, by summarizing the most up-to-date databases, which collect computationally predicted and/or experimentally validated miRNA-target and ceRNA-ceRNA interactions, as well as the widespread computational methods for discovering and modeling possible evidences of ceRNA-ceRNA interaction networks. These methods can be grouped in two categories: statistics-based methods exploit multivariate analysis to build ceRNA networks, by considering the miRNA expression levels when evaluating miRNA sponging relationships; mathematical methods build deterministic or stochastic models to analyze and predict the behavior of ceRNA cross talk.

Citing Articles

The Constrained Disorder Principle Overcomes the Challenges of Methods for Assessing Uncertainty in Biological Systems.

Ilan Y J Pers Med. 2025; 15(1).

PMID: 39852203 PMC: 11767140. DOI: 10.3390/jpm15010010.


Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy.

To K, Zhang H, Cho W Cancer Drug Resist. 2024; 7:37.

PMID: 39403602 PMC: 11472581. DOI: 10.20517/cdr.2024.66.


of Potential Noncoding RNAs Related to Spinal Cord Injury Based on Competing Endogenous RNAs.

Huang Z, Li X, Liu J, Wang H Mol Neurobiol. 2024; 61(12):10901-10915.

PMID: 38809369 DOI: 10.1007/s12035-024-04189-2.


ceRNA Network and WGCNA Analyses of Differentially Expressed Genes in Cervical Cancer Tissues for Association with Survival of Patients.

Luo Y, Liu Z, Hu X Reprod Sci. 2024; 31(8):2523-2533.

PMID: 38467964 DOI: 10.1007/s43032-024-01477-z.


Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma.

Liu P, Zhou L, Chen H, He Y, Li G, Hu K PeerJ. 2023; 11:e16242.

PMID: 37842058 PMC: 10573295. DOI: 10.7717/peerj.16242.


References
1.
Costa F . Non-coding RNAs, epigenetics and complexity. Gene. 2008; 410(1):9-17. DOI: 10.1016/j.gene.2007.12.008. View

2.
Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

3.
Poliseno L, Salmena L, Zhang J, Carver B, Haveman W, Pandolfi P . A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010; 465(7301):1033-8. PMC: 3206313. DOI: 10.1038/nature09144. View

4.
Gu S, Jin L, Zhang F, Sarnow P, Kay M . Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. Nat Struct Mol Biol. 2009; 16(2):144-50. PMC: 2713750. DOI: 10.1038/nsmb.1552. View

5.
Mukherji S, Ebert M, Zheng G, Tsang J, Sharp P, van Oudenaarden A . MicroRNAs can generate thresholds in target gene expression. Nat Genet. 2011; 43(9):854-9. PMC: 3163764. DOI: 10.1038/ng.905. View